Amneal Pharmaceuticals AMRX SEC Filings

NASDAQ AMRX
$17.26 +0.22 (+1.26%)
As of: Sep 9, 2026 · 12:53 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Amneal Pharmaceuticals, Inc. (AMRX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index